Hot Products

Fluoxymesterone/Halotestin 10

Item No.: 00117
Strength:  100 Tablets (10mg/tablet)
Trade names: Halotestin, Ora-Testryl, Ultandren, others
CAS Number :76-43-7
Formula: C20H29FO3 
Dosage Form: Tablet
Route: Oral
Description
Description

Halotelix is a steroid with anabolic and the most powerful androgenicactivity. The active ingredient of this drug is Fluoxymesterone.

Previously, Halotelix was used to treat delayed puberty in male -hypogonadism. Halotelix also was used in the treatment of breastcancer in women. But now in medicine Halotelix is no longer usedbut it is popular among athletes, Halotelix has performance-enhancingaggression, because it has established itself in sports such as rugby,martial arts, also this steroid increases aerobic performance oflightweight-athletes.

It is still completely unknown, what is the influence mechanism ofHalotelix, but it is assumed that the active ingredient has a non-receptor effect on the muscles.

Anabolic effect lasts up to g hours, to discover it in the blood may beduring in a period up to 2 months. Halotelix helps to quickly increasemuscle strength that allows an athlete to achieve good results. Inaddition to this, Halotelix has the following properties: improvesmuscle relief, increased vascularity, it has fat-burning propertiesincreases the density of the muscles. All these qualities makeHalotelix indispensable before the competition.

An athlete. who decided to use Halotelix should clarify its advantages:no aromatization, and thus there is no risk of gynecomastia; asignificant effect is achieved in the shortest possible time: Halotestinincreases the level of hemoglobin: it increases motivation.

It is worth remembering that Halotelix is very toxic to the liver andside effects include acne, prostate problems. Because of this, do notexceed the required dosage.

Halotelix dosage can vary within wide limits of 5-40 mg. It dependson age, weight of the athlete and his purposes. Halotelix cycle lengthcan be 2-4-6 weeks, do not use Halotestin longer The average intakeis 20-30 mg per day, by dividing the dose into two intakes. It is betterto use Fluoxymesterone in the morning and evening during meals, asit will work better than on an empty stomach. You also need to drinkFluoxymesterone with plenty of water Halotelix is powerful, that'swhy it is ideal for the preparation for a competition in bodybuildingBut for the current trainings it is better to give preference to othersteroids.

If an athlete wants to use for the first time Halotelix, he needs tostart with the lowest dose, For women Halotelix is not recommended.as there is a high risk of irreversible masculinization.

Halotelix is effective not only solo, it showed itself very well incombination with other drugs. We can consider several options foroptimal combinations of Halotelix and other anabolic steroids.

To avoid side effects, it should be remembered that in addition to theHalotelix it is necessary to use Nolvadex and also use Clomid for postcydle therapy.

Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
pop_close
pop_main
Newsletter